Next Article in Journal
Determinants of Self-Rated Health in a Representative Sample of a Rural Population: A Cross-Sectional Study in Greece
Previous Article in Journal
Suicide Mortality in Comparison to Traffic Accidents and Homicides as Causes of Unnatural Death. An Analysis of 14,441 Cases in Germany in the Year 2010
Int. J. Environ. Res. Public Health 2012, 9(3), 932-942; doi:10.3390/ijerph9030932
Article

Tobacco Addiction and Smoking Status in Heroin Addicts under Methadone vs. Buprenorphine Therapy

1
,
2
,
1
,
1
,
1
,
3
,
4
 and
1,*
1 Department of Internal Medicine, Addiction Unit, Verona University Hospital, 37134 Verona, Italy 2 Neuropsychopharmacology Laboratory, Section of Pharmacology, Department of Public Health & Community Medicine, University of Verona, 37134 Verona, Italy 3 Department of Internal Medicine, University of Verona, Policlinico G.B. Rossi, 37134 Verona, Italy 4 Scientific Intercentres Collaborative Drug Users Group, GICS, 37134 Verona, Italy
* Author to whom correspondence should be addressed.
Received: 14 February 2012 / Revised: 6 March 2012 / Accepted: 12 March 2012 / Published: 16 March 2012
View Full-Text   |   Download PDF [209 KB, uploaded 19 June 2014]

Abstract

Aims of the present investigation were: (i) to assess the prevalence of current smokers and relative smoking status among a large number of heroin addicts attending opioid-substitution therapy prevalence; (ii) to evaluate the relationship between the type (methadone, buprenorphine) and dosage of opioid substitution therapy and nicotine dependence. Three hundred and five (305) heroin addicts under opioid-substitution therapy were recruited at five Addiction Units. All participants completed a questionnaire assessing sociodemographic information, type and dose of opioid-substitution therapy, smoking history and status, Fagerström Test for Nicotine Dependence (FTND), and the Zung Self-Rating Depression scale (SDS). 298 subjects, out of 305 (97.2%) were smokers, with an average of 20.5 cigarette/day and a median FTND of 6. Our data confirmed the high prevalence of smokers among heroin addicts, the highest described in the literature to date among heroin addicts under substitution therapies, without any significant difference between methadone vs. buprenorphine therapy groups. There was no correlation between dose of methadone or buprenorphine and average number of cigarettes/day. Patients in substance abuse treatment very frequently smoke cigarettes and often die of tobacco-related diseases. Substance abuse treatment programs too often ignore tobacco use. We hope that these findings will help to incorporate smoking cessation in substance abuse treatments.
Keywords: tobacco smoking; methadone; buprenorphine; heroin; opioid substitution therapy tobacco smoking; methadone; buprenorphine; heroin; opioid substitution therapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Pajusco, B.; Chiamulera, C.; Quaglio, G.; Moro, L.; Casari, R.; Amen, G.; Faccini, M.; Lugoboni, F. Tobacco Addiction and Smoking Status in Heroin Addicts under Methadone vs. Buprenorphine Therapy. Int. J. Environ. Res. Public Health 2012, 9, 932-942.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert